{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:29Z","timestamp":1784557049634,"version":"3.55.0"},"reference-count":20,"publisher":"Bioscientifica","content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,10,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Erdheim-Chester disease (ECD), one type of systemic non-Langerhans cell histiocytosis, has been rarely seen and is characterized by the accumulation of foamy CD68+CD1a- histiocytes. We reported a case of ECD and reviewed the clinical features of 13 cases of ECD reported so far in China. A 53-year-old male was diagnosed with central diabetes insipidus in March 2014, followed by fever, splenomegaly and anemia in July 2014. His initial pituitary magnetic resonance imaging (MRI) revealed the absence of high signal at T1-weighted image in posterior pituitary without any lesion. A further positron emission tomography\/computer tomography (PET\/CT) images showed elevated metabolic activity of\n                    <jats:sup>18<\/jats:sup>\n                    F-2-fluro-D-deoxy-glucose (FDG) and low\n                    <jats:sup>13<\/jats:sup>\n                    N-NH3 uptake in the posterior pituitary, and multi-organ involvement. Biopsy at right femur lesion revealed that granulomatous infiltration of foamy histiocytes and Touton giant cells surrounded by fibrosis tissues. Immunohistochemistry stain was positive for CD68, negative for CD207\/Langerin and S-100. The diagnosis of ECD was confirmed and the treatment with pegylated interferon was effective. ECD was a possible immune-related disorder concluding from the IgG4 immunohistochemistry results. We summarized the pathological manifestations for ECD and its differential diagnosis from Langerhans cell histiocytosis (LCH) and Rosai-Dorfman disease (RDD). ECD should be considered by both pathologists and clinicians in the differential diagnosis when central diabetes insipidus is accompanied with multi-organ involvement, especially skeletal system involvement, or recurrent fever.\n                  <\/jats:p>\n                  <jats:sec>\n                    <jats:title>Learning points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>ECD should be considered when central diabetes insipidus is accompanied with multisystem involvement, especially symmetric\/asymmetric bone lesions, or recurrent fever.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>PET\/CT scanning was helpful for locating pituitary lesion, discovering multiple system involvement and indicating the biopsy sites.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Conducting proper immunohistochemistry stains was important for diagnosing ECD. ECD might be correlated with immune disorder.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/edm-15-0055","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T03:12:42Z","timestamp":1444273962000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":0,"title":["Chinese Erdheim-Chester disease: clinical-pathology-PET\/CT updates"],"prefix":"10.1530","volume":"2015","author":[{"given":"Huanyu","family":"Ding","sequence":"first","affiliation":[{"name":"1 Department of Endocrinology and Metabolism, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[{"name":"2 Department of Pathology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caishun","family":"Ruan","sequence":"additional","affiliation":[{"name":"3 Department of Endocrinology and Metabolism, Longyan People Hospital, Longyan, 364000, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[{"name":"4 Department of General Practice, Community Health Center of Qianjin Street, Tianhe District, Guangzhou, 510660, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hehua","family":"Wang","sequence":"additional","affiliation":[{"name":"5 Department of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangsong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department Nuclear Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Liao","sequence":"additional","affiliation":[{"name":"1 Department of Endocrinology and Metabolism, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"ref111","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.iop.0000197021.98742.09","article-title":"Association between Erdheim-Chester disease, Hashimoto thyroiditis, and familial thrombocytopenia","volume":"22","year":"2006","journal-title":"Ophthalmic Plastic and Reconstructive Surgery"},{"key":"ref181","first-page":"269359","article-title":"High-dose methotrexate for the treatment of relapsed central nervous system Erdheim-Chester disease","volume":"2014","year":"2014","journal-title":"Case Reports in Hematology"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/WNL.0000000000000832","article-title":"Marked efficacy of vemurafenib in suprasellar Erdheim-Chester disease","volume":"83","year":"2014","journal-title":"Neurology"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3904\/kjim.2013.28.1.81","article-title":"Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions","volume":"28","year":"2013","journal-title":"Korean Journal of Internal Medicine"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease","volume":"124","year":"2014","journal-title":"Blood"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease","volume":"124","year":"2014","journal-title":"Blood"},{"key":"ref81","first-page":"269359","article-title":"High-dose methotrexate for the treatment of relapsed central nervous system Erdheim-Chester disease","volume":"2014","year":"2014","journal-title":"Case Reports in Hematology"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.2012.46.9676","article-title":"BRAF mutations in Erdheim-Chester disease","volume":"31","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.iop.0000197021.98742.09","article-title":"Association between Erdheim-Chester disease, Hashimoto thyroiditis, and familial thrombocytopenia","volume":"22","year":"2006","journal-title":"Ophthalmic Plastic and Reconstructive Surgery"},{"key":"ref51","first-page":"44","article-title":"Dynamic 13N-ammonia PET: a new imaging method to diagnose hypopituitarism","volume":"46","year":"2005","journal-title":"Journal of Nuclear Medicine"},{"key":"ref151","first-page":"44","article-title":"Dynamic 13N-ammonia PET: a new imaging method to diagnose hypopituitarism","volume":"46","year":"2005","journal-title":"Journal of Nuclear Medicine"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","year":"2012","journal-title":"Blood"},{"key":"ref171","first-page":"3257","article-title":"Erdheim-Chester disease: a comprehensive review","volume":"34","year":"2014","journal-title":"Anticancer Research"},{"key":"ref01","first-page":"535","article-title":"Lipid cholesterol granulomatosis Degenerative and Inflammatory Diseases of Joints Philadelphia Lea","author":"Jaffe","year":"1972","journal-title":"Bone"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3904\/kjim.2013.28.1.81","article-title":"Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions","volume":"28","year":"2013","journal-title":"Korean Journal of Internal Medicine"},{"key":"ref71","first-page":"3257","article-title":"Erdheim-Chester disease: a comprehensive review","volume":"34","year":"2014","journal-title":"Anticancer Research"},{"key":"ref101","first-page":"535","article-title":"Lipid cholesterol granulomatosis Degenerative and Inflammatory Diseases of Joints Philadelphia Lea","author":"Jaffe","year":"1972","journal-title":"Bone"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","year":"2012","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.2012.46.9676","article-title":"BRAF mutations in Erdheim-Chester disease","volume":"31","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/WNL.0000000000000832","article-title":"Marked efficacy of vemurafenib in suprasellar Erdheim-Chester disease","volume":"83","year":"2014","journal-title":"Neurology"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2015\/1\/EDM15-0055.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2015\/1\/EDM15-0055.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:46:08Z","timestamp":1784555168000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1530\/edm-15-0055","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,1]]}}}